These results confirmed the complexity of this pathway in the onset of cardiometabolic disease; nevertheless, animal models suggest that only the complete blockade of IL-6 (both classic and trans-signaling) exacerbates obesity and insulin resistance [24], while this effect was not present in specific inhibition of the trans-signaling. This evidence concerns the gene IL6 and obesity due to melanocortin 4 receptor deficiency.